What execution and liquidity services does Drovix provide?

Drovix provides institutional-grade Agency STP execution, deep multi-source liquidity, and technology aligned to professional workflows.

Who does Drovix primarily serve?

Drovix focuses on professional market participants such as asset managers, hedge funds, and other institutions seeking robust FX execution and liquidity access.

Drovix operates under an authorised regulatory framework and applies institutional standards including segregated client funds and transparent execution practices.

What platforms and connectivity does Drovix support?

Drovix supports MetaTrader 5 and connectivity options suited to professional trading and algorithmic workflows across major asset classes.

How does Drovix approach execution latency?

Infrastructure is engineered for low-latency execution, with presence in Equinix facilities in London, New York, Tokyo, and Singapore.

Drovix.

Client Eligibility

Professional & institutionalclients only.

Drovix does not provide services to retail clients. Access is limited to professional clients, eligible counterparties, regulated financial institutions, funds, proprietary trading firms, brokers, family offices and other institutional clients that satisfy Drovix onboarding, KYB, suitability, credit and jurisdictional requirements.

Request institutional access Restricted jurisdictions

Who we onboard

Regulated financial institutions and banks
Broker-dealers and prime-of-prime brokers
Hedge funds, asset managers and CTAs
Proprietary trading firms and market-makers
Family offices qualifying as professional clients
Corporate treasury and institutional counterparties
Eligible counterparties under applicable regulatory classification
Technology partners and EMS/OMS vendors (integration-only counterparties)

Who we will not onboard

Retail clients or natural persons not qualifying as professional clients
Applicants located in or substantially connected to restricted jurisdictions
Failure to satisfy KYB, UBO, sanctions or AML screening requirements
Inability to evidence professional-client or eligible-counterparty status
Inadequate financial standing, credit profile or operational capacity
Material adverse media, regulatory enforcement or warning-list findings
Reverse-solicitation circumvention or marketing breaches
Other risk-based decisions in Drovix' sole discretion

Onboarding & due-diligence checklist

Legal Entity Identifier (LEI) where required

Certificate of incorporation, board resolution and authorised signatory list

Ultimate beneficial ownership (UBO) verification

Source of funds and source of wealth review

Audited financial statements where applicable

Regulatory licence verification (where the counterparty is itself regulated)

Jurisdiction and sanctions-screening review (EU, UN, UK, US OFAC, Mauritius)

Adverse-media and PEP screening; ongoing monitoring

Professional-client or eligible-counterparty classification and acknowledgement

Credit assessment and counterparty limit assignment

Suitability and product-knowledge assessment

Execution and onboarding documentation, master agreements (where applicable)

Drovix is institutional-only. Drovix does not onboard retail clients, does not migrate retail clients from affiliated businesses and does not permit its regulatory status, if any, to be used in marketing materials for unauthorised or retail-facing affiliated entities. Eligibility decisions are at Drovix' sole discretion and may be revisited at any time on a risk basis.